IceCure Medical Ltd (ICCM) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 911K | 1.28M | 850K | 525K | 725K | 875K | 662K | 1.01M | 736.35K | 1.32M | 327K | 937K |
| Revenue Growth % | 25.66% | 46.17% | 28.4% | -48.07% | -1.54% | -33.77% | 102.45% | 7.9% | 3.71% | 40.69% | -48.42% | 22.48% |
| Cost of Goods Sold | 616K | 679K | 573K | 394K | 507K | 458K | 427K | 481K | 469.76K | 722.12K | 350K | 503K |
| COGS % of Revenue | 67.62% | 53.09% | 67.41% | 75.05% | 69.93% | 52.34% | 64.5% | 47.58% | 63.8% | 54.66% | 107.03% | 53.68% |
| Gross Profit | 295K | 600K | 277K | 131K | 218K | 417K | 235K | 530K | 266.59K | 598.96K | -23K | 434K |
| Gross Margin % | 32.38% | 46.91% | 32.59% | 24.95% | 30.07% | 47.66% | 35.5% | 52.42% | 36.2% | 45.34% | -7.03% | 46.32% |
| Gross Profit Growth % | 35.32% | 43.88% | 17.87% | -75.28% | -18.23% | -30.38% | 1121.74% | 22.12% | -16.69% | 29.93% | -113.86% | 13.02% |
| Operating Expenses | 4.54M | 4.82M | 18.2M | 3.52M | 3.88M | 4.94M | 4.53M | 3.76M | 3.88M | 4.19M | 4.1M | 4.51M |
| OpEx % of Revenue | 498.57% | 376.54% | 2140.82% | 669.71% | 534.48% | 564.8% | 683.99% | 371.71% | 527.46% | 317.45% | 1253.82% | 481.86% |
| Selling, General & Admin | 2.33M | 2.52M | 2.35M | 1.8M | 2.21M | 3.25M | 2.66M | 2.17M | 1.95M | 2.1M | 1.9M | 2.44M |
| SG&A % of Revenue | 255.87% | 197.03% | 276.59% | 343.81% | 304.97% | 371.09% | 402.27% | 214.94% | 264.87% | 159.04% | 581.04% | 259.98% |
| Research & Development | 2.21M | 2.3M | 1.76M | 1.71M | 1.66M | 1.7M | 1.86M | 1.58M | 1.93M | 1.98M | 2.2M | 2.08M |
| R&D % of Revenue | 242.7% | 179.52% | 207.29% | 325.9% | 229.52% | 193.71% | 281.72% | 156.78% | 262.58% | 150.04% | 672.78% | 221.88% |
| Other Operating Expenses | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.25M | -4.22M | -17.92M | -3.38M | -3.66M | -4.53M | -4.29M | -3.23M | -3.62M | -3.59M | -4.12M | -4.08M |
| Operating Margin % | -466.19% | -329.63% | -2108.24% | -644.76% | -504.41% | -517.14% | -648.49% | -319.29% | -491.25% | -272.11% | -1260.86% | -435.54% |
| Operating Income Growth % | -16.13% | 6.83% | -317.42% | -4.86% | -1.1% | -25.88% | -4.12% | 20.9% | 8.58% | 8.58% | -0.54% | 4.67% |
| EBITDA | -4.18M | -4.14M | -17.85M | -3.32M | -3.57M | -4.44M | -4.21M | -3.15M | -3.53M | -3.51M | -4.04M | -4M |
| EBITDA Margin % | -458.62% | -324.08% | -2099.65% | -632.95% | -492.14% | -507.77% | -635.95% | -311.18% | -479.81% | -265.5% | -1236.29% | -427.25% |
| EBITDA Growth % | -17.1% | 6.71% | -323.92% | -5.63% | -0.99% | -26.67% | -4.14% | 21.42% | 8.93% | 9.09% | -0.29% | 5.34% |
| D&A (Non-Cash Add-back) | 69K | 71K | 73K | 62K | 89K | 82K | 83K | 82K | 84.24K | 87.37K | 80.33K | 77.66K |
| EBIT | -4.25M | -4.22M | -3.84M | -3.38M | -3.66M | -4.53M | -4.29M | -3.23M | -3.65M | -3.42M | -4.12M | -4.08M |
| Net Interest Income | -27K | -30K | -23K | 21K | 69K | 46K | 144K | 147K | 41K | 420K | 123K | 192K |
| Interest Income | 0 | 0 | 0 | 21K | 69K | 46K | 144K | 147K | 41K | 420K | 123K | 192K |
| Interest Expense | 27K | 30K | 23K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -27K | -30K | 14.06M | 21K | 69K | 46K | 144K | 147K | 41K | 420K | 123K | 192K |
| Pretax Income | -4.27M | -4.25M | -3.86M | -3.36M | -3.59M | -4.48M | -4.15M | -3.08M | -3.58M | -3.15M | -4M | -3.89M |
| Pretax Margin % | -469.15% | -331.98% | -454% | -640.76% | -494.9% | -511.89% | -626.74% | -304.75% | -485.73% | -238.65% | -1223.24% | -415.05% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43.56K | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -1.38% | 0% | 0% |
| Net Income | -4.27M | -4.25M | -3.86M | -3.36M | -3.59M | -4.48M | -4.15M | -3.08M | -3.58M | -3.15M | -4M | -3.89M |
| Net Margin % | -469.15% | -331.98% | -454% | -640.76% | -494.9% | -511.89% | -626.74% | -304.75% | -485.73% | -238.65% | -1223.24% | -415.05% |
| Net Income Growth % | -19.12% | 5.2% | 6.99% | -9.19% | -0.32% | -42.07% | -3.72% | 20.78% | 0.06% | 20.63% | 0.37% | 18.32% |
| Net Income (Continuing) | -4.27M | -4.25M | -3.86M | -3.36M | -3.59M | -4.48M | -4.15M | -3.08M | -3.61M | -3M | -4M | -3.89M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.74 | -1.75 | -1.81 | -1.72 | -1.87 | -2.42 | -2.38 | -1.88 | -2.30 | -2.07 | -2.63 | -2.56 |
| EPS Growth % | 6.75% | 27.67% | 23.74% | 8.47% | 18.69% | -16.81% | 9.69% | 26.53% | 2.42% | 37.27% | 20.27% | 34.46% |
| EPS (Basic) | -1.74 | -1.75 | -1.77 | -1.72 | -1.87 | -2.42 | -2.38 | -1.88 | -2.30 | -2.07 | -2.63 | -2.56 |
| Diluted Shares Outstanding | 2.45M | 2.43M | 2.18M | 1.96M | 1.92M | 1.85M | 1.75M | 1.64M | 1.56M | 1.52M | 1.52M | 1.52M |
| Basic Shares Outstanding | 2.45M | 2.43M | 2.13M | 1.96M | 1.92M | 1.85M | 1.75M | 1.64M | 1.56M | 1.52M | 1.52M | 1.52M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |